• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Infect. Serological immunochromatographic approach in diagnosis with SARS-CoV-2 infected COVID-19 patients

tetano

Editor, Senior Moderator
J Infect. 2020 Apr 10. pii: S0163-4453(20)30175-4. doi: 10.1016/j.jinf.2020.03.051. [Epub ahead of print]
Serological immunochromatographic approach in diagnosis with SARS-CoV-2 infected COVID-19 patients.


Pan Y[SUP]1[/SUP], Li X[SUP]2[/SUP], Yang G[SUP]1[/SUP], Fan J[SUP]1[/SUP], Tang Y[SUP]1[/SUP], Zhao J[SUP]1[/SUP], Long X[SUP]1[/SUP], Guo S[SUP]1[/SUP], Zhao Z[SUP]1[/SUP], Liu Y[SUP]1[/SUP], Hu H[SUP]1[/SUP], Xue H[SUP]3[/SUP], Li Y[SUP]4[/SUP].

Author information




Abstract

An outbreak of new coronavirus SARS-CoV-2 was occurred in Wuhan, China and rapidly spread to other cities and nations. The standard diagnostic approach that widely adopted in the clinic is nucleic acid detection by real-time RT-PCR. However, the false-negative rate of the technique is unneglectable and serological methods are urgently warranted. Here, we presented the colloidal gold-based immunochromatographic (ICG) strip targeting viral IgM or IgG antibody and compared it with real-time RT-PCR. The sensitivity of ICG assay with IgM and IgG combinatorial detection in nucleic acid confirmed cases were 11.1%, 92.9% and 96.8% at the early stage (1-7 days after onset), intermediate stage (8-14 days after onset), and late stage (more than 15 days), respectively. The ICG detection capacity in nucleic acid-negative suspected cases was 43.6%. In addition, the concordance of whole blood samples and plasma showed Cohen's kappa value of 0.93, which represented the almost perfect agreement between two types of samples. In conclusion, serological ICG strip assay in detecting SARS-CoV-2 infection is both sensitive and consistent, which is considered as an excellent supplementary approach in clinical application.
Copyright ? 2020 Elsevier Ltd. All rights reserved.



KEYWORDS:

Colloidal gold-based; Covid-19; Immunochromatographic strip; Real-time RT-PCR; SARS-CoV-2; Serology


PMID:32283141DOI:10.1016/j.jinf.2020.03.051
 
Back
Top